Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FLEXBUMIN® 5% safely and effectively. See full prescribing information for FLEXBUMIN 5%. FLEXBUMIN® 5% Albumin (Human), USP, 5% Solution, for intravenous useInitial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-other
FLEXBUMIN® 5% [Albumin (Human)] is indicated for hypovolemia, hypoalbuminemia and cardiopulmonary bypass surgery. FLEXBUMIN 5% [Albumin (Human)] is indicated for reversing hypovolemia. When hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 25% albumin should be used.4,6 FLEXBUMIN 5% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 (1)Inadequate production (e.g., malnutrition, burns, major injury, infections) (2)Excessive catabolism (e.g., burns, major injury, pancreatitis) (3)Loss from the body (e.g., hemorrhage, excessive renal excretion, burn exudates) (4)Redistribution within the body (e.g., major surgery, various inflammatory conditions) FLEXBUMIN 5% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. Burns After the first 24 hours, FLEXBUMIN 5% is indicated in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace protein loss which accompanies any severe burn.4,6 Preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass surgery. FLEXBUMIN 5% is indicated as a component of the pump prime during cardiopulmonary bypass procedures.4,6 Albumin is not indicated as an intravenous nutrient.
- generic_name
- albumin human
- product_names
- Albumin Human
- ndc
- 0944-0495, 0944-0495-06, 0944-0495-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en